Atopic Dermatitis study
Do you have moderate-to-severe ATOPIC DERMATITIS that is impacting your quality of life?
A new study is investigating the effectiveness and safety of an investigational medication for moderate-to-severe Atopic Dermatitis. This medication may help relieve your symptoms.
- Aged 18 years and above
- Have a doctor’s diagnosis of chronic Atopic Dermatitis for at least 1 year
- History of inadequate response to stable regimen of topical corticosteroid or calcineurin inhibitors (drug that act on the immune system to reduce skin inflammation) within 3 months
Please consider joining this clinical trial to receive this investigational medication for a period of 16 weeks.
Please speak to your doctor if you/your friends/family are interested. By joining this study, you will be helping others by contributing to Atopic Dermatitis research.
If this sounds of interest, then simply register your details below and we'll be in touch.